Literature DB >> 4109736

Insulin antibodies in aetiology of labile diabetes.

K Dixon, P D Exon, H R Hughes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4109736     DOI: 10.1016/s0140-6736(72)92841-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Editorial: control of diabetes and insulin antibodies.

Authors: 
Journal:  Br Med J       Date:  1976-02-28

2.  Serum IRI in insulin-treated diabetics during a 24-hour period.

Authors:  S M Rasmussen; L G Heding; E Parbst; A Volund
Journal:  Diabetologia       Date:  1975-04       Impact factor: 10.122

3.  The clinical significance of highly purified pig-insulin preparations.

Authors:  T Deckert; O O Andersen; J E Poulsen
Journal:  Diabetologia       Date:  1974-12       Impact factor: 10.122

4.  Brittle diabetes--present concepts.

Authors:  G V Gill; S Walford; K G Alberti
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

5.  Insulin antibodies and hypoglycemia in diabetic patients. Can a quantitative analysis of antibody binding predict the risk of hypoglycemia?

Authors:  M R Kim; L R Sheeler; N Mansharamani; M T Haug; C Faiman; M K Gupta
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

6.  Insulin immunogenicity in pregnancy: maternal and fetal studies.

Authors:  R Mylvaganam; J M Stowers; J M Steel; J Wallace; J C MacHendry; A D Wright
Journal:  Diabetologia       Date:  1983-01       Impact factor: 10.122

7.  Antibody formation and insulin requirements in diabetic children during treatment with purified commercial pork insulins.

Authors:  B Weber; J Tech; H Schmidt; U Oberdisse
Journal:  Eur J Pediatr       Date:  1978-06-20       Impact factor: 3.183

8.  Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins.

Authors:  R S Gray; D Q Borsey; D M Fraser; A B Kurtz; S Rainbow; A F Smith; L J Duncan; B F Clarke
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

9.  The immunogenic properties of a highly purified insulin preparation.

Authors:  N T Manning; M I Drury
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

10.  Effect of dilution on immunoreactive insulin activity of human plasma.

Authors:  H Sankaran; M G Harrington
Journal:  Ir J Med Sci       Date:  1976-12       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.